Atlas Trials

First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Clinical trial NCT07505043 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07505043
Sponsor
SUNHO(China)BioPharmaceutical CO., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy SubjectsHyperlipidemia, Hypertriglyceridemia
Start date
2026-03-01
Primary completion
2027-02-28
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.